The global Continuos Glucose Monitoring market size was valued at US$ million in 2023. With growing demand in downstream market, the Continuos Glucose Monitoring is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Continuos Glucose Monitoring market. Continuos Glucose Monitoring are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Continuos Glucose Monitoring. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Continuos Glucose Monitoring market.
Continuous glucose monitoring (CGM) is a method used to monitor blood glucose levels continuously throughout the day and night. CGM systems consist of a sensor placed under the skin, which measures glucose levels and transmits data to a receiver or smartphone.
The market for continuous glucose monitoring is driven by the increasing adoption of CGM systems for improved diabetes management, especially in individuals with type 1 diabetes and insulin-dependent type 2 diabetes. Technological advancements in CGM sensors, such as improved accuracy and longer wear time, have also contributed to the market's growth.
Key Features:
The report on Continuos Glucose Monitoring market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Continuos Glucose Monitoring market. It may include historical data, market segmentation by Type (e.g., Retrospective CGM (r-CGM), Real-time continuous glucose monitoring (RT-CGM)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Continuos Glucose Monitoring market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Continuos Glucose Monitoring market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Continuos Glucose Monitoring industry. This include advancements in Continuos Glucose Monitoring technology, Continuos Glucose Monitoring new entrants, Continuos Glucose Monitoring new investment, and other innovations that are shaping the future of Continuos Glucose Monitoring.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Continuos Glucose Monitoring market. It includes factors influencing customer ' purchasing decisions, preferences for Continuos Glucose Monitoring product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Continuos Glucose Monitoring market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Continuos Glucose Monitoring market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Continuos Glucose Monitoring market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Continuos Glucose Monitoring industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Continuos Glucose Monitoring market.
Market Segmentation:
Continuos Glucose Monitoring market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Retrospective CGM (r-CGM)
Real-time continuous glucose monitoring (RT-CGM)
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Yicheng
Acon
Medtrum Technologies
MicroTech Medical, Inc
Sinocare
Hybio Pharmaceutical
Lepu Medical
Yuyue Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Continuos Glucose Monitoring market?
What factors are driving Continuos Glucose Monitoring market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Continuos Glucose Monitoring market opportunities vary by end market size?
How does Continuos Glucose Monitoring break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Continuos Glucose Monitoring Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Continuos Glucose Monitoring by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Continuos Glucose Monitoring by Country/Region, 2019, 2023 & 2030
2.2 Continuos Glucose Monitoring Segment by Type
2.2.1 Retrospective CGM (r-CGM)
2.2.2 Real-time continuous glucose monitoring (RT-CGM)
2.3 Continuos Glucose Monitoring Sales by Type
2.3.1 Global Continuos Glucose Monitoring Sales Market Share by Type (2019-2024)
2.3.2 Global Continuos Glucose Monitoring Revenue and Market Share by Type (2019-2024)
2.3.3 Global Continuos Glucose Monitoring Sale Price by Type (2019-2024)
2.4 Continuos Glucose Monitoring Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Continuos Glucose Monitoring Sales by Application
2.5.1 Global Continuos Glucose Monitoring Sale Market Share by Application (2019-2024)
2.5.2 Global Continuos Glucose Monitoring Revenue and Market Share by Application (2019-2024)
2.5.3 Global Continuos Glucose Monitoring Sale Price by Application (2019-2024)
3 Global Continuos Glucose Monitoring by Company
3.1 Global Continuos Glucose Monitoring Breakdown Data by Company
3.1.1 Global Continuos Glucose Monitoring Annual Sales by Company (2019-2024)
3.1.2 Global Continuos Glucose Monitoring Sales Market Share by Company (2019-2024)
3.2 Global Continuos Glucose Monitoring Annual Revenue by Company (2019-2024)
3.2.1 Global Continuos Glucose Monitoring Revenue by Company (2019-2024)
3.2.2 Global Continuos Glucose Monitoring Revenue Market Share by Company (2019-2024)
3.3 Global Continuos Glucose Monitoring Sale Price by Company
3.4 Key Manufacturers Continuos Glucose Monitoring Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Continuos Glucose Monitoring Product Location Distribution
3.4.2 Players Continuos Glucose Monitoring Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Continuos Glucose Monitoring by Geographic Region
4.1 World Historic Continuos Glucose Monitoring Market Size by Geographic Region (2019-2024)
4.1.1 Global Continuos Glucose Monitoring Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Continuos Glucose Monitoring Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Continuos Glucose Monitoring Market Size by Country/Region (2019-2024)
4.2.1 Global Continuos Glucose Monitoring Annual Sales by Country/Region (2019-2024)
4.2.2 Global Continuos Glucose Monitoring Annual Revenue by Country/Region (2019-2024)
4.3 Americas Continuos Glucose Monitoring Sales Growth
4.4 APAC Continuos Glucose Monitoring Sales Growth
4.5 Europe Continuos Glucose Monitoring Sales Growth
4.6 Middle East & Africa Continuos Glucose Monitoring Sales Growth
5 Americas
5.1 Americas Continuos Glucose Monitoring Sales by Country
5.1.1 Americas Continuos Glucose Monitoring Sales by Country (2019-2024)
5.1.2 Americas Continuos Glucose Monitoring Revenue by Country (2019-2024)
5.2 Americas Continuos Glucose Monitoring Sales by Type
5.3 Americas Continuos Glucose Monitoring Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuos Glucose Monitoring Sales by Region
6.1.1 APAC Continuos Glucose Monitoring Sales by Region (2019-2024)
6.1.2 APAC Continuos Glucose Monitoring Revenue by Region (2019-2024)
6.2 APAC Continuos Glucose Monitoring Sales by Type
6.3 APAC Continuos Glucose Monitoring Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Continuos Glucose Monitoring by Country
7.1.1 Europe Continuos Glucose Monitoring Sales by Country (2019-2024)
7.1.2 Europe Continuos Glucose Monitoring Revenue by Country (2019-2024)
7.2 Europe Continuos Glucose Monitoring Sales by Type
7.3 Europe Continuos Glucose Monitoring Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Continuos Glucose Monitoring by Country
8.1.1 Middle East & Africa Continuos Glucose Monitoring Sales by Country (2019-2024)
8.1.2 Middle East & Africa Continuos Glucose Monitoring Revenue by Country (2019-2024)
8.2 Middle East & Africa Continuos Glucose Monitoring Sales by Type
8.3 Middle East & Africa Continuos Glucose Monitoring Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Continuos Glucose Monitoring
10.3 Manufacturing Process Analysis of Continuos Glucose Monitoring
10.4 Industry Chain Structure of Continuos Glucose Monitoring
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Continuos Glucose Monitoring Distributors
11.3 Continuos Glucose Monitoring Customer
12 World Forecast Review for Continuos Glucose Monitoring by Geographic Region
12.1 Global Continuos Glucose Monitoring Market Size Forecast by Region
12.1.1 Global Continuos Glucose Monitoring Forecast by Region (2025-2030)
12.1.2 Global Continuos Glucose Monitoring Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Continuos Glucose Monitoring Forecast by Type
12.7 Global Continuos Glucose Monitoring Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Continuos Glucose Monitoring Product Portfolios and Specifications
13.1.3 Roche Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 LifeScan
13.2.1 LifeScan Company Information
13.2.2 LifeScan Continuos Glucose Monitoring Product Portfolios and Specifications
13.2.3 LifeScan Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 LifeScan Main Business Overview
13.2.5 LifeScan Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Continuos Glucose Monitoring Product Portfolios and Specifications
13.3.3 Abbott Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Ascensia
13.4.1 Ascensia Company Information
13.4.2 Ascensia Continuos Glucose Monitoring Product Portfolios and Specifications
13.4.3 Ascensia Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ascensia Main Business Overview
13.4.5 Ascensia Latest Developments
13.5 ARKRAY
13.5.1 ARKRAY Company Information
13.5.2 ARKRAY Continuos Glucose Monitoring Product Portfolios and Specifications
13.5.3 ARKRAY Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 ARKRAY Main Business Overview
13.5.5 ARKRAY Latest Developments
13.6 I-SENS
13.6.1 I-SENS Company Information
13.6.2 I-SENS Continuos Glucose Monitoring Product Portfolios and Specifications
13.6.3 I-SENS Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 I-SENS Main Business Overview
13.6.5 I-SENS Latest Developments
13.7 Omron
13.7.1 Omron Company Information
13.7.2 Omron Continuos Glucose Monitoring Product Portfolios and Specifications
13.7.3 Omron Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Omron Main Business Overview
13.7.5 Omron Latest Developments
13.8 B. Braun
13.8.1 B. Braun Company Information
13.8.2 B. Braun Continuos Glucose Monitoring Product Portfolios and Specifications
13.8.3 B. Braun Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 B. Braun Main Business Overview
13.8.5 B. Braun Latest Developments
13.9 77 Elektronika
13.9.1 77 Elektronika Company Information
13.9.2 77 Elektronika Continuos Glucose Monitoring Product Portfolios and Specifications
13.9.3 77 Elektronika Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 77 Elektronika Main Business Overview
13.9.5 77 Elektronika Latest Developments
13.10 AgaMatrix
13.10.1 AgaMatrix Company Information
13.10.2 AgaMatrix Continuos Glucose Monitoring Product Portfolios and Specifications
13.10.3 AgaMatrix Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 AgaMatrix Main Business Overview
13.10.5 AgaMatrix Latest Developments
13.11 ALL Medicus
13.11.1 ALL Medicus Company Information
13.11.2 ALL Medicus Continuos Glucose Monitoring Product Portfolios and Specifications
13.11.3 ALL Medicus Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 ALL Medicus Main Business Overview
13.11.5 ALL Medicus Latest Developments
13.12 Terumo
13.12.1 Terumo Company Information
13.12.2 Terumo Continuos Glucose Monitoring Product Portfolios and Specifications
13.12.3 Terumo Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Terumo Main Business Overview
13.12.5 Terumo Latest Developments
13.13 Yicheng
13.13.1 Yicheng Company Information
13.13.2 Yicheng Continuos Glucose Monitoring Product Portfolios and Specifications
13.13.3 Yicheng Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Yicheng Main Business Overview
13.13.5 Yicheng Latest Developments
13.14 Acon
13.14.1 Acon Company Information
13.14.2 Acon Continuos Glucose Monitoring Product Portfolios and Specifications
13.14.3 Acon Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Acon Main Business Overview
13.14.5 Acon Latest Developments
13.15 Medtrum Technologies
13.15.1 Medtrum Technologies Company Information
13.15.2 Medtrum Technologies Continuos Glucose Monitoring Product Portfolios and Specifications
13.15.3 Medtrum Technologies Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Medtrum Technologies Main Business Overview
13.15.5 Medtrum Technologies Latest Developments
13.16 MicroTech Medical, Inc
13.16.1 MicroTech Medical, Inc Company Information
13.16.2 MicroTech Medical, Inc Continuos Glucose Monitoring Product Portfolios and Specifications
13.16.3 MicroTech Medical, Inc Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 MicroTech Medical, Inc Main Business Overview
13.16.5 MicroTech Medical, Inc Latest Developments
13.17 Sinocare
13.17.1 Sinocare Company Information
13.17.2 Sinocare Continuos Glucose Monitoring Product Portfolios and Specifications
13.17.3 Sinocare Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Sinocare Main Business Overview
13.17.5 Sinocare Latest Developments
13.18 Hybio Pharmaceutical
13.18.1 Hybio Pharmaceutical Company Information
13.18.2 Hybio Pharmaceutical Continuos Glucose Monitoring Product Portfolios and Specifications
13.18.3 Hybio Pharmaceutical Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Hybio Pharmaceutical Main Business Overview
13.18.5 Hybio Pharmaceutical Latest Developments
13.19 Lepu Medical
13.19.1 Lepu Medical Company Information
13.19.2 Lepu Medical Continuos Glucose Monitoring Product Portfolios and Specifications
13.19.3 Lepu Medical Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Lepu Medical Main Business Overview
13.19.5 Lepu Medical Latest Developments
13.20 Yuyue Medical
13.20.1 Yuyue Medical Company Information
13.20.2 Yuyue Medical Continuos Glucose Monitoring Product Portfolios and Specifications
13.20.3 Yuyue Medical Continuos Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Yuyue Medical Main Business Overview
13.20.5 Yuyue Medical Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
